Revolutionizing Beauty

Register to Join Webinar

    Revolutionizing Beauty: The Future of Cosmetics with Skin Tissue Engineering

    In contemporary era, quality of living has improved. People are paying more attention to their appearance. The scale of the cosmetic market has increased significantly. Contemporary cosmetics now offer benefits beyond basic functions, such as moisturizing, whitening, sun protection, spot removal, and anti-aging effects. However, safety concerns like irritation, corrosion, and heavy metals have emerged, making cosmetic toxicology testing crucial. This testing ensures products are safe and free from harmful substances before reaching consumers. Traditional detection methods, including UV spectroscopy, high-performance liquid
    chromatography (HPLC), capillary electrophoresis etc. rely on instrumentation and method selection, which are less sensitive and more complex to perform. Additionally, animal experiments are used for in vivo efficacy evaluations, and two-dimensional (2D) cell models are employed for in vitro testing. Due to significant interspecies differences and limitations of traditional 2D cell cultures, which fail to replicate the complex 3D microenvironment and hysiological conditions of human skin, there are onsiderable challenges in accurately modelling tissue structure, cell behaviour, and predicting dose effectiveness and toxicity. Engineered skin tissue has emerged with the advent of tissue engineering technology as an emerging bioengineering technology.

    This seminar will cover:

    • Basics of Skin Tissue Engineering: An overview of the scientific principles and technologies that form the foundation of skin tissue engineering, including the usage of scaffolds, cellular elements, and bioreactors to produce functional skin tissues.
    • Contemporary applications of Cosmetics: An exploration into how engineered skin tissues is being applied in cosmetic product testing, reducing the necessity for animal experimentation and ensuring greater precision in predicting human skin responses. We’ll discuss case studies where these technologies have been successfully utilized in the development and safety evaluations of products.
    • Innovations in Anti-Aging and Regenerative Skin care: Discover how engineered skin tissues are revolutionizing anti-aging treatments and regenerative skincare solutions. We’ll discuss the latest studies and clinical progress in utilizing engineered tissues to rejuvenate and repair the skin, opening new avenues for fighting the signs of aging.
    • Ethical and Regulatory considerations: Addressing the ethical considerations and the regulatory framework related to the application of skin tissue engineering in cosmetics. We’ll outline the measures required to ensure adherence to standards and the safety of consumers.
    • Future Prospects and Possibilities: An insight into what lies ahead, highlighting new trends and potential prospects for expansion within the cosmetic industry through the adoption of skin tissue engineering. We’ll explore how these advancements can lead to more customized and effective skincare products.

    Biosketch of Speaker

    Dr. Swati Chitrangi is a leading expert in the field of cell culture and regenerative medicine, currently serving as the Head of Production-Cell Culture at the Advancells Group in India. With over 15 years of international experience, Dr.Swati has significantly contributed to the development, manufacturing, and commercialization of stem cell and primary cell products for drug discovery. She holds a PhD and completed her postdoctoral studies at IIT Bombay, where her research on the chemotherapeutic effects of exosomes derived from stem cells was supported by prestigious fellowships from DBT, ICMR, and JNMF. Furthermore, Dr. Swati holds an MBA in Strategic Management from the Indian Institute of Management (IIM L 2025).

    Throughout her career, Dr. Swati has made pioneering advancements in 3D tissue engineering. During her doctoral studies, she developed innovative 3D liver models using scaffolds and Human Umbilical Cord-derived Mesenchymal Stem Cells, evaluating drug metabolism through Mass Spectroscopy, with her work being published in leading international journals. Her expertise extends to induced pluripotent stem cells (iPSCs) technology, where she created multiple well-characterized iPSC lines and differentiated them into various cell types, significantly advancing drug discovery and disease modelling.

    Dr. Swati has led groundbreaking projects on patient-derived organoids for cancer research, enhancing the efficiency of drug screening and improving clinical trial success rates. Her expertise in biobanking and stem cell research has earned her national and international recognition. At Advancells Group, she spearheads initiatives in regenerative medicine and the development of next-generation cellular models for drug discovery. Her current projects focus on primary epithelial cells, hepatocytes, skin cells, and stem cells.
    In the webinar “Transforming Beauty: The Role of Skin Tissue Engineering in the Cosmetic Industry,” Dr. Swati will share her extensive knowledge and insights into the revolutionary application of skin tissue engineering in cosmetics. Attendees will gain a deep understanding of the fundamentals of skin tissue engineering, its current applications in cosmetics, innovations in anti-aging and regenerative skincare, ethical and regulatory considerations, and future trends and opportunities in the cosmetic industry.

    Dr.Swati’s leadership, analytical skills, and effective communication are crucial in achieving research goals and driving innovation in cellular research and therapies. Her contributions are shaping the future of the cosmetic industry, ensuring the development of safer, more effective, and ethically-produced skincare products.